Spartan Cube

Spartan Cube

The world's smallest DNA analyzer.

Meet the Spartan Cube

The Spartan Cube is the world's smallest DNA analyzer. Samples are collected with a non-invasive swab and inserted into a single-use DNA test cartridge. Inside the analyzer, the cartridge extracts the DNA and makes millions of DNA copies based on Nobel Prize-winning chemistry called Polymerase Chain Reaction (PCR). An optical system detects the increased fluorescence and algorithms automatically generate a test result.

Rapid DNA results.

Traditional lab-based DNA tests can take days to weeks for results. In contrast, the Spartan Cube goes from sample to result in less than 1 hour. Finally, you can get DNA results whenever and wherever you need them.

Spartan Cube

Breakthrough Design.

If Apple made a personal DNA testing product, it might look something like the Spartan Cube: A minimalist, anodized aluminum box, about the size of a large coffee mug, and roughly as heavy as a small laptop.

Intuitive Interface.

A clean and thoughtful design gets you up and running in seconds. There is a single button to open the device and only one way to insert the DNA test cartridge. Visual instructions are displayed on screen so you never miss a step. Press "Go" and walk away. The device runs automatically and generates your results.

The Spartan Cube is used for a wide variety of test applications

One platform. Multiple applications.

The Spartan cube can run different DNA test cartridges on the same device—just like a coffee maker uses pods. Our current products include tests for precision medicine and environmental water safety. And we're developing new tests for infectious disease and veterinary diagnostics. Learn more

The Spartan Cube builds on 13 years of cutting edge R&D.

  • 2005

    • The Spartan Cube is used for a wide variety of test applications

      Spartan Bioscience Founded

  • 2006

    • The Spartan Cube is used for a wide variety of test applications

      Spartan DX DNA analyzer launched

  • 2010

    • The Spartan Cube is used for a wide variety of test applications

      Spartan RX CYP2C19 test introduced

  • 2012

    • The Spartan Cube is used for a wide variety of test applications

      ISO 13485 Certification

    • The Spartan Cube is used for a wide variety of test applications

      Included in Mayo Clinic CYP2C19 5,300-patient trial

    • The Spartan Cube is used for a wide variety of test applications

      FDA clearance for Spartan RX CYP2C19

    • The Spartan Cube is used for a wide variety of test applications

      Included in POPular Genetics European CYP2C19 2,488-patient trial

  • 2014

    • The Spartan Cube is used for a wide variety of test applications

      Canada and Korea approve CYP2C19 test

  • 2016

    • The Spartan Cube is used for a wide variety of test applications

      Spartan Cube announced

    • The Spartan Cube is used for a wide variety of test applications

      APOE test launched

    • The Spartan Cube is used for a wide variety of test applications

      Environmental (Legionella) test launched

  • 2018

    • The Spartan Cube is used for a wide variety of test applications

      Spartan Cube receives CE IVD certification

    • The Spartan Cube is used for a wide variety of test applications

      CDC and NY state validate Spartan's Legionella test

    • The Spartan Cube is used for a wide variety of test applications

      POPular Genetics trial published in NEJM

    • The Spartan Cube is used for a wide variety of test applications

      APOE partnership with Global Alzheimer's Platform

  • 2020

    • The Spartan Cube is used for a wide variety of test applications

      European commercialization launch—5 distributors in Europe

  • 2022

    • The Spartan Cube is used for a wide variety of test applications

      In Development

      Test for infectious disease, veterinary diagnostics and more

Research

Accuracy and precision of Legionella isolation by US laboratories in the ELITE program pilot study

Environmental
  • The CDC conducted a proficiency study of 20 ELITE-certified Legionella culture testing labs.
  • On average, the culture labs undercounted actual Legionella concentrations by 17-fold and values differed between labs by 6-fold.
Read the full study

Prospective CYP2C19 genotyping to guide antiplatelet therapy following percutaneous coronary intervention

Medical
  • Spartan's rapid CYP2C19 genotyping test was implemented at the University of Pennsylvania Health System for patients receiving percutaneous coronary intervention (PCI)
  • 28% of patients carried loss-of-function CYP2C19 mutations
  • Prasugrel or ticagrelor were used in 30% of the genotyped group vs. 21% of the usual care group who were not genotyped
Read the full study

Precision Medicine at the University of Alabama at Birmingham: Laying the foundational processes through implementation of Genotype-Guided Antiplatelet Therapy

Medical
  • This independent report describes concordance of the Spartan RX with gold standard genotyping.

The use described in this publication is not approved or cleared by the US FDA. This study was supported in part by University of Alabama at Birmingham's Health Service Foundations' General Endowment Fund; The Hugh Kaul Precision Medicine Institute; by grants from the National Institutes of Health (grant numbers RO1HL092173, K24HL133373 to N.L.); and the National Human Genome Research Institute of the National Institutes of Health (grant number T32HG008961 to B.D.). Spartan knows of no other financial interests. Spartan knows of no significant risks or safety concerns associated with the use described in this publication.

Read the full study
View all evidence
Spartan Cube

Learn more about
the Spartan Cube